Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to evaluate the effects of a 4 month Zumba training program on cardiometabolic, hormonal, inflammatory, hepatic, renal, and functional parameters in overweight and obese women. Participants will be classified according to menopausal status (pre- or post-menopausal) and randomly assigned to an exercise group or a non-exercise control group.
Overweight and obesity are associated with metabolic dysregulation, hormonal imbalance, chronic inflammation, and reduced physical capacity. Zumba training is a dance-based aerobic exercise that can improve cardiovascular fitness, energy expenditure, and adherence to physical activity programs.
This study will assess the effects of a 4 month Zumba training program (4 sessions per week, 60 minutes per session) on: Body composition and anthropometric measures, Aerobic capacity, Hormonal profile, Lipid profile, Inflammatory biomarkers, Liver enzymes, Renal function markers, Electrolytes, Muscle enzymes, Pre- and post-training measurements will be taken under standardized conditions.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental Group 1:Pre-menopausal | Experimental | performed Zumba training, 4 × 60 min/week, 4 months |
|
| Control Group 1 | No Intervention | No training intervention was intended for the control group. | |
| Experimental Group 2:Post-menopausal | Experimental | performed Zumba training, 4 × 60 min/week, 4 months |
|
| Control group 2 | No Intervention | No training intervention was intended for the control group. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Zumba training | Behavioral | Participants assigned to the experimental groups will perform a supervised Zumba training program for 10 weeks, with 4 sessions per week, each session lasting 60 minutes. Sessions will include a standardized warm-up (10 minutes), choreographed dance-based aerobic sequences performed at moderate intensity (40 minutes), and a cool-down with stretching (10 minutes). |
| Measure | Description | Time Frame |
|---|---|---|
| Body Mass Index (BMI) | BMI calculated as weight (kg) divided by height squared (m²). | Baseline and after 4 months of Zumba intervention. |
| Body Fat Percentage | Total body fat measured by digital scale (Tanita BC-533). | Baseline and after 4 months of Zumba intervention. |
| Waist Circumference | Measured at the narrowest point between the rib cage and iliac crest using a tape measure. | Baseline and after 4 months of Zumba intervention. |
| Waist-Hip Ratio | Calculated by dividing waist circumference by hip circumference. | Baseline and after 4 months of Zumba intervention. |
| Hip Circumference | Measured at the widest point of the hips using a tape measure. | Baseline and after 4 months of Zumba intervention. |
| Prolactin | Serum prolactin concentration (ng/mL). | Baseline and after 4 months of the intervention. |
| Testosterone | Serum testosterone concentration (ng/dL). | Baseline and after 4 months of the intervention. |
| Cortisol | Serum cortisol concentration (µg/dL). |
| Measure | Description | Time Frame |
|---|---|---|
| Resting Heart Rate | Measured using automated device (Omron BP652). | Baseline and after 4 months of Zumba intervention. |
| Blood Pressure (Systolic and Diastolic) | Measured using an automated arm cuff (Omron BP652). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
female
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Wissal Abassi, Dr | Contact | +21693304684 | wissalabassi93@gmail.com | |
| wissal Abassi, Dr | Contact | wissalabassi93@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Wissal abassi | Research Unit "Sport Sciences, Health and Movement"(UR22JS01) High Institute of Sport and Physical Education of Kef, University of Jendouba, 7100 Kef, Tunisia. | Principal Investigator |
Not provided
For confidentiality reasons, all data from this study will be available upon request.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Baseline and after 4 months of the intervention. |
| Progesterone | Serum progesterone concentration (ng/mL). | Baseline and after 4 months of the intervention. |
| Estradiol | Serum estradiol concentration (pg/mL). | Baseline and after 4 months of the intervention. |
| Follicle-Stimulating Hormone (FSH) | Serum FSH concentration (mIU/mL). | Baseline and after 4 months of the intervention. |
| Luteinizing Hormone (LH) | Serum LH concentration (mIU/mL). | Baseline and after 4 months of the intervention. |
| Thyroid Stimulating Hormone (TSH) | Serum TSH concentration (µIU/mL). | Baseline and after 4 months of the intervention. |
| Free Thyroxine (FT4) | Serum free T4 concentration (ng/dL). | Baseline and after 4 months of the intervention. |
| Parathyroid Hormone (PTH) | Serum PTH concentration (pg/mL). | Baseline and after 4 months of the intervention. |
| Total Cholesterol | Serum total cholesterol concentration (mg/dL). | Baseline and after 4 months of the intervention. |
| High-Density Lipoprotein (HDL) Cholesterol | Serum HDL cholesterol concentration (mg/dL). | Baseline and after 4 months of the intervention. |
| Low-Density Lipoprotein (LDL) Cholesterol | Serum LDL cholesterol concentration (mg/dL). | Baseline and after 4 months of the intervention. |
| Triglycerides | Serum triglyceride concentration (mg/dL). | Baseline and after 4 months of the intervention. |
| C-Reactive Protein (CRP) | Serum CRP concentration (mg/L). | Baseline and after 4 months of the intervention. |
| Erythrocyte Sedimentation Rate (ESR) | ESR measured in mm/hr. | Baseline and after 4 months of the intervention. |
| Complete Blood Count (CBC) | Includes neutrophils, lymphocytes, monocytes, eosinophils, basophils (cells/µL). | Baseline and after 4 months of the intervention. |
| Alanine Aminotransferase (ALT) | Serum ALT concentration measured in U/L. | Baseline and after 4 months of the intervention. |
| Aspartate Aminotransferase (AST) | Serum AST concentration measured in U/L. | Baseline and after 4 months of the intervention. |
| Alkaline Phosphatase (ALP) | Serum ALP concentration measured in U/L. | Baseline and after 4 months of the intervention. |
| Gamma-Glutamyl Transferase (GGT) | Serum GGT concentration measured in U/L. | Baseline and after 4 months of the intervention. |
| Lactate Dehydrogenase (LDH) | Serum LDH concentration measured in U/L. | Baseline and after the 4 months of the intervention. |
| Gamma-Glutamyl Transferase (GGT) | Serum GGT concentration measured in U/L. | Baseline and after the 4 months of the intervention. |
| Bilirubin Total | Total serum bilirubin concentration measured in mg/dL. | Baseline and after the 4 months of the intervention. |
| Bilirubin Direct | Direct (conjugated) serum bilirubin concentration measured in mg/dL. | Baseline and after the 4 months of the intervention. |
| Creatinine | Serum creatinine concentration measured in mg/dL, indicator of kidney function. | Baseline and after 4 months of the intervention. |
| Urea | Serum urea concentration measured in mg/dL, indicator of kidney function. | Baseline and after 4 months of the intervention. |
| Uric Acid | Serum uric acid concentration measured in mg/dL, indicator of kidney function. | Baseline and after 4 months of the intervention. |
| Sodium (Na) | Serum sodium concentration measured in mmol/L. | Baseline and after 4 months of the intervention. |
| Potassium (K) | Serum potassium concentration measured in mmol/L. | Baseline and after 4 months of the intervention. |
| Calcium (Ca) | Serum calcium concentration measured in mg/dL. | Baseline and after 4 months of training. |
| Magnesium (Mg) | Serum magnesium concentration measured in mg/dL. | Baseline and after 4 months of training. |
| Phosphate (PO₄) | Serum phosphate concentration measured in mg/dL. | Baseline and after 4 months of training. |
| Creatine Phosphokinase (CPK) | Serum CPK concentration measured in U/L, indicator of muscle damage. | Baseline and after 4 months of training. |
| Lactate Dehydrogenase (LDH) | Serum LDH concentration measured in U/L, indicator of muscle and tissue damage. | Baseline and after 4 months of training. |
| Baseline and after 4 months of Zumba intervention. |
| 6-Minute Walk Test (6MWT) Distance | Distance walked in 6 minutes on a 30-meter straight corridor. | Baseline and after 4 months of Zumba intervention. |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |